top of page

Top Scientists Leading Tomorrow's Treatments

Ymmunobio is committed to developing preclinical breakthroughs toward improving how cancer therapies are developed.


Dr. Katrin Rupalla & Dr. Peter Schiemann co-founded Ymmunobio in 2021 as a way to advance developments solid tumor research. Since that time, Ymmunobio has assembled a distinguished team of scientific and clinical leaders who are united in transforming how cancer and autoimmune diseases are treated.

Meet the Team

Scientific Advisory Board

Board of Directors

bottom of page